Risk of SARS-CoV-2 reinfection after natural infection

LANCET

ELSEVIER SCIENCE INC

1. UK Medical Research Council Newton [MR/S019553/1, MR/R02622X/1, MR/V036939/1]
2. National Institute for Health Research Imperial Biomedical Research Centre: Institute of Translational Medicine and Therapeutics
3. Cystic Fibrosis Trust Strategic Research Centre
4. Horizon 2020 Marie Curie Actions
5. UK Research and Innovation [MR/S019553/1, MR/R02622X/1, MR/V036939/1]